Author

G. C. Hildebrandt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

C. D. Jennings· 1 shared E. Strattan· 1 shared F. Marti· 1 shared J. Du· 1 shared J. M. Eckenrode· 1 shared J. P. Collard· 1 shared J. R. Rivas· 1 shared J. S. Thorson· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. D. Jennings

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivJul 15, 2020

Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia

J. R. Rivas, Y. Liu, S. S. Alhakeem…·S. Bondada

This study shows that suppressing IL-10 enhances T-cell antitumor activity and improves responses to checkpoint blockade in CLL.

DOI 10.1038/s41375-021-01217-1

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivJun 12, 2019

Mast cells are mediators of fibrosis and effector cell recruitment in dermal chronic graft-versus-host disease

E. Strattan, S. Palaniyandi, R. Kumari…·G. C. Hildebrandt

This study shows mast cells contribute to fibrosis and effector cell recruitment in dermal chronic GVHD, suggesting they are potential therapeutic targets.

DOI 10.1200/jco.2019.37.15_suppl.7

𝕏 PostBluesky